Drug intelligence / Profile preview

Qinlian Duonang

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Qinlian Duonang (芩连多囊颗粒) is a traditional Chinese medicine (TCM) granule preparation. The name suggests it contains Scutellaria baicalensis (黄芩, Huangqin) and Coptis chinensis (黄连, Huanglian), which are commonly used in TCM for their heat-clearing and detoxifying properties. The specific indication implied by the name "Duonang" may relate to polycystic conditions, but there is no widely recognized standard indication or official documentation for this exact product in major regulatory or clinical databases. It is likely intended for use in conditions involving heat-toxicity or damp-heat patterns according to TCM theory.

Brand names: 芩连多囊颗粒
Other names: Qinlian Duonang Granules芩连多囊颗粒

Beyond the preview

Go deeper on Qinlian Duonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinlian Duonang.

Explore the full profile